Is Iovance Biotherapeutics, Inc. (IOVA) a Buy, Sell, or Hold?
NASDAQ : IOVA
Iovance Biotherapeutics, Inc. — Analyst Ratings
$4.9 USD
-$0.09 (-1.8%)
- Volume
- 13.21M
- Average Volume
- 15.27M
- Market Capitalization
- $2.19B
- P/E Ratio
- -5.33
- Dividend Yield
- 0.00%
- Price Target
- $5.00
- Year High
- $5.64
- Year Low
- $1.76
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.60
Analyst Consensus Summary
Consensus Rating
Sell
20 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-2.0%
vs Current Price
Price Target
$5.00
Average TargetPrice Target Range
Lowest Target
$2.00
145.0% UPSIDE
Average Target
$5.00
Median Estimate
Highest Target
$5.00
-2.0% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 20
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 15 | 5 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Goldman Sachs | Andrea Newkirk | $2 | $2.44 | 2026-02-05 07:53 AM | -18.0% |
| UBS | David Dai | $2 | $1.66 | 2025-05-16 04:43 AM | 20.5% |
| Piper Sandler | Joseph Catanzaro | $7.5 | $5.85 | 2025-01-31 06:40 AM | 28.2% |
| UBS | David Dai | $17 | $9.82 | 2024-10-23 11:53 PM | 73.1% |
| Stifel Nicolaus | Benjamin Burnett | $23 | $3.97 | 2024-08-09 03:56 AM | 479.3% |
| Robert W. Baird | Colleen Kusy | $24 | $3.97 | 2024-08-09 02:35 AM | 504.5% |
| Piper Sandler | Joseph Catanzaro | $10 | $9.25 | 2024-07-28 10:11 PM | 8.1% |